Serum levels of glial cell line‐derived neurotrophic factor and multiple neurotransmitters: In relation to cognitive performance in Parkinson's disease with mild cognitive impairment
Authors:
- 25 October 2019
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 35 (2) , 153-162
Abstract
Objectives: Mild cognitive impairment is a common non‐motor feature of Parkinson's disease, termed PD‐MCI. But there is a scarcity of data on the role of glial cell line‐derived neurotrophic factor (GDNF) and neurotransmitters in pathogenesis of PD‐MCI. The aim of this project was to detect the serum levels of GDNF and multiple neurotranmitters and explore their relationships with cognitive performance in PD‐MCI patients.Methods: Neuropsychological testing was administered to PD patients and healthy controls to investigate different domains of cognitive function. Serum levels of GDNF and four cognition‐related neurotransmitters including Dopamine metabolites Homovanillic acid (HVA), acetylcholine (Ach), γ‐aminobutyric acid (GABA) and 5‐hydroxytryptamine (5‐HT) were detected by enzyme‐linked immunosorbent assay and liquid chromatography‐electrospray ionization tandem mass spectrometry analysis respectively.Results: The more serious cognitive impairment of PD, the lower levels of GDNF, HVA and 5‐HT. In PD‐MCI patients, the levels of GDNF, HVA, Ach, 5‐HT, and GABA had a significant positive correlation with Digit span backward test (DSB‐T) scores and negative correlation with the scores of Trail Making Test A (TMT‐A) and Trail Making Test B (TMT‐B) respectively. Effect size analysis showed that GDNF and GDNF*Ach have a significant effect on DSB‐T, TMT‐A and TMT‐B respectively; GDNF*HVA, GDNF*5‐HT and GDNF*GABA play important part in Auditory Verbal Learning Test separately.Conclusions: Serum GDNF may be involved in the impairment of attention, memory and executive function of PD‐MCI patients, by acting alone or in conjunction with neurotransmitters (HVA, 5‐HT, GABA, and Ach).Keywords
Funding Information
- National Natural Science Foundation of China (81772688)
This publication has 37 references indexed in Scilit:
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesMovement Disorders, 2012
- Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive ControlBiological Psychiatry, 2011
- Mild cognitive impairment in Parkinson diseaseNeurology, 2010
- Expression of GDNF transgene in astrocytes improves cognitive deficits in aged ratsNeurobiology of Aging, 2008
- Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedureJournal of Pharmaceutical and Biomedical Analysis, 2006
- Ventral hippocampal α7 and α4β2 nicotinic receptor blockade and clozapine effects on memory in female ratsPsychopharmacology, 2006
- Performance deficit of α7 nicotinic receptor knockout mice in a delayed matching‐to‐place task suggests a mild impairment of working/episodic‐like memoryGenes, Brain and Behavior, 2005
- Least angle regressionThe Annals of Statistics, 2004
- Trail Making Test, Part B as a Measure of Executive Control: Validation Using a Set-Switching ParadigmJournal of Clinical and Experimental Neuropsychology, 2000
- Relationships between Parts A and B of the Trail Making TestJournal of Clinical Psychology, 1987